Skip to main content

Advisory Board

The Advisory Board serves in an advisory capacity to the Center's Director. Board members’ duties include fundraising, public speaking, and other public relations activities to advance public awareness of successful adult, cord blood and related stem three cell therapeutic options. The Board is required to meet at least four times each year and will be authorized to meet upon the call of the chairperson.

The Center’s director serves as an ex officio member of the Board. Advisory Board members may serve for only three consecutive terms and its members will serve without compensation. The bill provides for Board vacancies and appointments of successor members. The Governor will appoint the Board chairperson.

David Prentice, PhD.
Chair, Midwest Stem Cell Therapy Center Advisory Board
Vice President and Research Director, Charlotte Lozier Institute
Adjunct Professor of Molecular Genetics, John Paul II Institute
The Catholic University of America

Representative Dan Hawkins
Representative, State of Kansas
Chair, Health and Human Services
Vice Chair, Home and Community Based Services Oversight

Sunil Abhyankar, MD
Professor of Medicine
Director of Midwest Stem Cell Therapy Center
Medical Director - Pheresis and Cell Processing
Division of Hematologic Malignancies and Cellular Therapeutics

James L. Sherley, MD, PhD
President and CEO
Asymmetrex, LLC

Senator Mike Thompson
Senator, State of Kansas
Senate Public Health and Welfare Committee

Lee Norman, MD
Secretary, Kansas Department of Health and Environment

Bassam Mattar, MD, FACP
Oncologist, Wichita, KS

Dr. Matthias Salathe, MD
Chair, Internal Medicine
School of Medicine

James L. Sherley, MD, PhD
President and CEO
Asymmetrex, LLC

Senator Mike Thompson
Senator, State of Kansas
Senate Public Health and Welfare Committee

Mr. Jeff Wright
VP of Cancer Services
The University of Kansas Cancer Center

Frank Blecha, MD
College of Veterinary Medicine
University Distinguished Professor
Associate Dean of Research
Kansas State University

Scott Weir, Pharm D, PhD
Professor of Clinical Pharmacology
Director, Institute for Advancing Medial Innovation, KUMC
Assoc Director, Translational Research, University of Kansas Cancer Center

Jennifer Robinson, PhD
Assistant Professor
Chemical and Petroleum Engineering
University of Kansas

Ms. Ruth Colyer
Patient community representative
Kansas

Greg Lakin, DO
Family Medicine Physician
Wichita, KS

Weijing Sun, MD, FACP
Division Director Medical Oncology
School of Medicine

Last modified: Jun 23, 2021
I want to...
ID=x15624